Study finds weight loss medications linked to lower dementia and heart risks

A recent study published in Nature Medicine found that GLP-1 medications, such as Ozempic and Wegovy, are linked to lower risks of dementia, heart failure, and severe infections. The study analyzed data from over 2 million patients, revealing significant health benefits. Patients using GLP-1 drugs had a 24% lower risk of liver failure and a 22% reduced chance of cardiac arrest compared to those on other diabetes treatments. However, these medications also carry risks, including digestive issues and joint problems. The study indicates that GLP-1 medications may positively impact brain health, showing a 12% lower risk of dementia. Despite these findings, experts caution that the results may not apply to all populations, as most participants were older white men with diabetes.